Prevalence and Nondisclosure of Complementary and Alternative Medicine Use in Patients with Cancer and Cancer Survivors in the United States

Nina N. Sanford; David J. Sher; Chul Ahn; Ayal A. Aizer; Brandon A. Mahal

doi:10.1001/jamaoncol.2019.0349

Prevalence and Nondisclosure of Complementary and Alternative Medicine Use in Patients with Cancer and Cancer Survivors in the United States

Nina N. Sanford, David J. Sher, Chul Ahn, Ayal A. Aizer, Brandon A. Mahal

Research output: Contribution to journal › Letter › peer-review

Original language	English (US)
Pages (from-to)	735-737
Number of pages	3
Journal	JAMA Oncology
Volume	5
Issue number	5
DOIs	https://doi.org/10.1001/jamaoncol.2019.0349
State	Published - May 2019

ASJC Scopus subject areas

Oncology
Cancer Research

Access to Document

10.1001/jamaoncol.2019.0349

Cite this

@article{e26e5283e3144529af1aed18aa9ead1b,

title = "Prevalence and Nondisclosure of Complementary and Alternative Medicine Use in Patients with Cancer and Cancer Survivors in the United States",

author = "Sanford, {Nina N.} and Sher, {David J.} and Chul Ahn and Aizer, {Ayal A.} and Mahal, {Brandon A.}",

note = "Funding Information: Funding/Support: Dr Mahal reports funding from the American Society of Radiation Oncology and the Prostate Cancer Foundation. Funding Information: Funding/Support: Dr Lindvall was supported by a Junior Faculty Research Award from the National Palliative Care Research Center (NPCRC), New York, NY and a Faculty Development Award from the Gloria Spivak Fund, Boston, MA.",

year = "2019",

month = may,

doi = "10.1001/jamaoncol.2019.0349",

language = "English (US)",

volume = "5",

pages = "735--737",

journal = "JAMA Oncology",

issn = "2374-2437",

publisher = "American Medical Association",

number = "5",

}

TY - JOUR

T1 - Prevalence and Nondisclosure of Complementary and Alternative Medicine Use in Patients with Cancer and Cancer Survivors in the United States

AU - Sanford, Nina N.

AU - Sher, David J.

AU - Ahn, Chul

AU - Aizer, Ayal A.

AU - Mahal, Brandon A.

N1 - Funding Information: Funding/Support: Dr Mahal reports funding from the American Society of Radiation Oncology and the Prostate Cancer Foundation. Funding Information: Funding/Support: Dr Lindvall was supported by a Junior Faculty Research Award from the National Palliative Care Research Center (NPCRC), New York, NY and a Faculty Development Award from the Gloria Spivak Fund, Boston, MA.

PY - 2019/5

Y1 - 2019/5

UR - http://www.scopus.com/inward/record.url?scp=85064269116&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85064269116&partnerID=8YFLogxK

U2 - 10.1001/jamaoncol.2019.0349

DO - 10.1001/jamaoncol.2019.0349

M3 - Letter

C2 - 30973579

AN - SCOPUS:85064269116

SN - 2374-2437

VL - 5

SP - 735

EP - 737

JO - JAMA Oncology

JF - JAMA Oncology

IS - 5

ER -

Prevalence and Nondisclosure of Complementary and Alternative Medicine Use in Patients with Cancer and Cancer Survivors in the United States

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this